跳至主要内容
临床试验/NCT02244307
NCT02244307已完成不适用

Evolution of Patients Suffering From Benign Prostatic Hyperplasia (BPH) Treated With Alpha-adrenergic Blockade (JOSEPHINE)

Boehringer Ingelheim0 个研究点目标入组 4,561 人开始时间: 2000年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
4,561
主要终点
Assessment of prognosis factors for having recourse to prostatic surgery

研究概览

简要总结

The primary objective of this observational study was the assessment of prognosis factors for having recourse to prostatic surgery in patients with BPH who were administered class-1 alpha blockers. The secondary objectives were the assessment of the time from alpha-adrenergic blockade treatment initiation to surgery and the evolution of patients during the study.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
Male
接受健康志愿者

入选标准

  • Any patient with BPH for whom alpha-blocker treatment is indicated
  • Patients who are already on class-1 alpha-blockers can only participate in the study if all information required is known and/or available

排除标准

  • Patient's follow-up not possible
  • Patients participating in another study
  • History of BPH surgery
  • Prostate cancer

研究组 & 干预措施

Patients with BPH treated with alpha-andrenergic blockade

干预措施: alpha-adrenergic blocker (Drug)

结局指标

主要结局

Assessment of prognosis factors for having recourse to prostatic surgery

时间窗: up to 2 years

次要结局

  • Percentage of patients with ongoing BPH treatment(up to 2 years)
  • Time form alpha-adrenergic blockade treatment initiation to surgery(up to 2 years)
  • Occurrence of concomitant BPH diseases(up to 2 years)
  • Total International Prostate Symptom Score (IPSS)(up to 2 years)

研究者

申办方类型
Industry
责任方
Sponsor

相似试验

Observational Study in Patients Suffering From... | 临床试验